Home›Companies›Healthcare›Ambient Clinical Analytics

Ambient Clinical Analytics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 14, 2026·Suggest an edit

About Ambient Clinical Analytics

Ambient Clinical Analytics is a private company based in Rochester, Minnesota. It has reported $10,274,555 raised in 11 offerings on Form D since January 2014. Its chief executive is Allen Berning.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 15, 2025Jan 14, 2026$200,000of $2.7M target1$200KEquity, Series B Preferred StockRule 506(b)Form D ↗
Mar 21, 2024Apr 4, 2024$1,650,000of $5.0M target1$1.6MEquity, Series B Preferred StockRule 506(b)Form D ↗
Jan 7, 2021Jan 22, 2021$300,000of $800K target1$300KDebt, OptionsRule 506(b)Form D ↗
Mar 31, 2020Apr 27, 2020$525,000of $750K target3$175KDebt, OptionsRule 506(b)Form D ↗
Jun 10, 2019Jun 20, 2019$600,000of $1.2M target3$200KDebt, Options, 2019 Convertible Note PurchaseRule 506(b)Form D ↗
Jul 17, 2018Jul 31, 2018$110,000of $300K target1$110KDebt, Options, Convertible Promissory NotesRule 506(b)Form D ↗
May 14, 2018May 29, 2018$1,100,000of $1.5M target3$366KEquity, Options, Series A Convertible Preferred StockRule 506(b)Form D ↗
Feb 1, 2017Feb 9, 2017$3,926,755of $5.3M target38$103KEquity, Options, Series A and Series A-1 Convertible Preferred StockRule 506(b)Form D ↗
Feb 16, 2016Feb 25, 2016$100,000of $1.5M target2$50,000Debt, Securities on exercise, Convertible promissory notesRule 506(b)Form D ↗
Mar 3, 2015Mar 13, 2015amended Aug 27, 2015$577,000of $700K target14$41,214Debt, Securities on exercise, Convertible promissory notesRule 506(b)Form D/A ↗1 earlier filing
Jan 7, 2014Jan 17, 2014$1,185,800of $1.5M target4$296KDebt, Convertible promissory notesRule 506(b)Form D ↗
Total, 11 offerings$10,274,555

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ambient Clinical Analytics's Form D filed Jan 14, 2026.

TK
Tim Kuebelbeck
Executive officer
GL
Greg Lea
Director
AB
Allen Berning
President and Chief Executive Officer, director
BP

Earlier filings also listed Robert Greenglass (director, last listed Jan 2021), Matthijs Blokhuis (director, last listed Jan 2021), Drew Dashier (director, last listed Jan 2021) and Tyler Stowater (director, last listed Apr 2020).

Sources

  1. SECAmbient Clinical Analytics, Inc. Form D, filed Mar 13, 2015
  2. SECAmbient Clinical Analytics, Inc. filing history